+499.5%
MRNA vs HST
+38.1%
+461.4%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | HST | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +0.3% | -2.5% | -2.5% |
| 7D | +5.5% | -1.0% | +6.5% | +6.3% |
| 30D | +158.7% | -12.3% | +171.0% | +188.1% |
| 3M | +182.1% | -6.4% | +188.5% | +196.7% |
| 6M | +151.8% | +15.0% | +136.8% | +123.9% |
| YTD | +393.6% | +30.5% | +363.0% | +299.2% |
| 1Y | +499.5% | +35.7% | +463.8% | +362.4% |
| All | +499.5% | +38.1% | +461.4% | +362.4% |
Cumulative growth
Daily Returns
Daily percentage return beside HST.
Daily Out/Under-Performance
Portfolio return minus HST return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × HST return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded HST wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling